Indonesia: Life Sciences, Biotechnology & Nanotechnology

Indonesia's Constitutional Court has reinstated restrictions on patenting second medical uses of known products, reversing a 2024 reform that had opened pathways for such protection. The decision creates a critical distinction for pharmaceutical patent applicants based on filing dates, with applications submitted during the brief window when the restriction was lifted receiving different treatment than those filed after the Court's ruling.

Many businesses in Indonesia have been forced to temporarily cease their activities because of COVID-19. Some factories are still operating to ensure the continuation of production.